Daniel O'Mahony - BioPharma 4.0 & The Role of AI in Drug Manufacturing

We welcome Daniel O'Mahony to AI Uncovered. Daniel is a senior manager of sales and business consulting with Körber Pharma, a pharma manufacturing software company. Along with his work at Körber, Dan lectures with the national institute of bioprocessing research and training and at the Atlantic Technical University covering topics like BioPharma 4.0 and digital transformation.

In this episode, Tim and Dan look at the impact of AI on the pharmaceutical manufacturing processes and the delicate balance between digital transformation, risk, and productivity gains in life sciences. They discuss why Ireland has been a hub for manufacturing and pharmaceutical growth over the last 60 years. Next, they dig into the digital transformation happening in drug manufacturing, the role of AI on the process, and the future of personalized drugs. 

Dan has a masters degrees in bioprocessing from Atlantic Technical University and in Pharmaceutical business and technology from Griffith College. He is based in Dublin, Ireland. 

Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries.

With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across their organization.

Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team and uses his expertise to manage the wonderful world of product.